Piper initiates JMKE at Overweight with $29 target
Piper starts coverage of JMKE with an Overweight rating and a $29 price target, with no additional catalyst supplied.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.